FDA authorizes Pfizer’s Covid booster shots for people 65 and older and other vulnerable Americans
The Food and Drug Administration authorized Pfizer and BioNTech’s Covid-19 booster shots for people 65 and older and other vulnerable Americans six months after they complete their first two doses, making many Americans eligible to receive the shots now.